AGOSTO – DICIEMBRE 2020
La evolución de la pandemia COVID-19 desde el mes de marzo que se reportó el primer caso ha impactado muy fuertemente al sistema de salud pública y privada del país debido principalmente al número de casos y personas ...fallecidas.
more
interim guidance, 27 May 2021
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizin...g that there is no one-size-fits-all approach to managing cases and outbreaks of COVID-19. Each country should assess its risk and rapidly implement the necessary measures at the appropriate scale to reduce both COVID-19 transmission and economic, public and social impacts.
more
Данные технические руководящие указания предназначены для сотрудников МФОККиКП и
национальных обществ, участвующих в глобальных операциях, и, прежде всего, для
...отрудников, осуществляющих координацию деятельности по предоставлению защиты,
учету гендерных факторов и обеспечению широкого общественного участия, а также
работников медицинских программ. Важнейшие информационные сообщения и основные
группы, подвергающиеся риску социальной изоляции доступны для всех сотрудников
Красного Креста и Красного Полумесяца
more
Информационный бюллетень Июнь 2020 г.
Уязвимые группы населения в контексте
ответных мер в отношении COVID-19
Vuln...erable populations during COVID-19 response - Children and adolescents deprived of liberty
more
More than 8 million children have access to distance learning thanks to partnerships with 322 radio stations and 23 TV channels
1.2 million community masks distributed
25 million people reached with key messages on how to prevent COVID-19 ...through mass media channels (300 radio stations and 50 TV channels)
64,283 calls managed by the COVID-19 Hotline
71,532 people (including 21,415 children) affected by COVID-19 and 6,005 frontline workers provided with psychosocial support since the beginning of the epidemic
more
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the object...ives of COVID-19 vaccination programmes and links those to target groups for vaccination. This information is valuable to countries and globally while specific policies will be developed once vaccines become available.
This document it available in Arabic, Chinese and Russian
more
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as referen...ce for policymakers, laboratory leads, implementing partners, and experts on use case scenarios and associated testing algorithms for COVID-19 antigen tests. It recommends the use of antigen tests to increase access to testing and enable timely results for persons with or without symptoms in specific settings. The document will be reviewed and updated as more evidence becomes available regarding the use of rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from global studies and evaluation efforts.
more
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the ...ghlight medbox">COVID-19 pandemic, noting that the impact of quarantine and testing is likely to vary according to levels of ongoing community transmission, and in the context of ECDC’s current advice that non-essential travel should be avoided during the end-of year festive period
more
Material in multiple languages
CANVax is the first online database of its kind in Canada to support immunization program planning and promotional activities to improve vaccine acceptance and uptake in Canada. CANVax houses a collection of curated evidence based products and resources to make it eas...ier for public health professionals to access and gather resources to inform activities aimed at improving vaccine coverage.
more
Responding to COVID-19: Highlights of a Survey in ETHIOPIASummary•Almost all Ethiopiansknow about COVID-19 and basic understanding about transmission and the importance of regular hand washing is ...high. However, a sizeable minority seek more information, which may help address some misconceptions on avoidance and ‘cures.’•There is strong support for government response and high levels of trust in information coming from governments.•Ethiopians believe that COVID-19 will be a big problem for their country and that they would be seriously impacted but personally feel at relatively low risk.•Family and friends play an important role in conveying local information.
more
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requir...ing improvements or sustained actions have been identified across the 9 strategic pillars of World Health Organization (WHO)’s COVID-19 Strategic Preparedness and Response Plan and an additional pillar for the country’s response beyond health. On an overall, the review aims to enhance and sustain the national response with a particular focus on strengthening the health systems.
more
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants w...ho received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
22 July 2022. This document provides the case definitions for public health surveillance of COVID-19 in humans caused by SARS-COV-2 infection.
Actualizadas en el documento titulado «Vigilancia de salud pública en relación con la COVID-19» publicado el 16 de diciembre de 2020